120.1201-Lifetime risks of cardiovascular disease_Berry, nejm.pdf | 524.08Kb | February 10 2012 |
130.1201-1 Determinants of MRI detected carotid plaque components. Rotterdam study_van den Bouwhuijsen, jacc.pdf | 253.15Kb | February 10 2012 |
130.1201-2 The time has come for clinical CV trials with plaque chracterisation as an endpoint. Editorial_Fayad, jacc.pdf | 111.30Kb | February 10 2012 |
136.1202-Impact of a healthy lifestyle on all-cause and CV mortality after stroke in the USA_Towfighi, jnnp ++.pdf | 206.81Kb | February 10 2012 |
143.1202-Adherence to Dietary Approaches to Stop Hypertension (DASH)-style diet vs Risks of CVD and VTE_Fitzgerald, JTH.pdf | 176.76Kb | February 10 2012 |
15v.1202-Congenital anomalies of the IVC_Malaki, Clin Radiol.pdf | 1.38Mb | February 10 2012 |
212.1202-Cerebrovascular disease in 48 countries. Secular trends in mortality 1950-2005_Mirzaei, jnnp ++.pdf | 712.29Kb | February 10 2012 |
213.1202-RF management for stroke. A never-ending challenge for health behaviors of diet and physical activity_Kokubo, CO Neurol.pdf | 203.89Kb | February 10 2012 |
217.1201-Prediction of CV events by Inflammatory markers ..._Versaci, Mayo Clin Proceed..pdf | 286.96Kb | February 10 2012 |
241.1202-1 Relationships between recent IPH and Stroke RF in patients with CAS. HIRISC study_Turc, ATVB.pdf | 303.72Kb | February 10 2012 |
241.1202-2 IntraPlaque Hemorrhage, An imaging marker for AthS plaque destabilization ..._Pasterkamp, ATVB.pdf | 367.10Kb | February 10 2012 |
241.1202-Changes in carotid plaque echogenicity with time since the stroke onset ..._Martinez-Sanchez, UMB.pdf | 297.28Kb | February 10 2012 |
242.1202-Imaging of the carotid artery. Review_Saba, AthS.pdf | 2.25Mb | February 10 2012 |
244.1202-Carotid stenosis at MDCTA. Is there a threshold in mm that determines clinical significance_Saba, CVIR.pdf | 374.86Kb | February 10 2012 |
246.1202-Risk of recurrent stroke in patients with silent brain infarction ..._Weber, Stroke.pdf | 368.45Kb | February 10 2012 |
251.1201-Revascularisation carotide EC. Recommendations 2011-Mas, Consensus Cardio.pdf | 578.29Kb | February 10 2012 |
251.1202-Carotid artery disease and Interventional therapy_Mohr, Curr Opin Neurol.pdf | 134.69Kb | February 10 2012 |
252.1112-Clinical considerations in the management of ASx cas_Taussky, Neurosurg Focus ++.pdf | 1.04Mb | February 10 2012 |
252.1112-Strategies for ASx carotid stenosis_Doe, Neurosurg Focus ++.pdf | 5.15Mb | February 10 2012 |
252.1201-1 Decision-making in ASx cas. RCT_Silver, Neurology.pdf | 219.47Kb | February 10 2012 |
252.1201-2 Understanding risk in ASx cas. Editorial_Saposnik, Neurology.pdf | 144.09Kb | February 10 2012 |
252.1201ep-Role of Statin therapy and Angiotensin blockade in patients with ASx moderate cas_Durham, Ann Vasc Surg.pdf | 449.15Kb | February 10 2012 |
255.1202-CASt trial. Conduct, results, Critique, and current recommendations_Macdonald, CVIR.pdf | 250.62Kb | February 10 2012 |
255.1202-CASt, 2011 NICE guidelines_Neequaye, Heart.pdf | 62.00Kb | February 10 2012 |
255.1202-Cost implications of more widespread CASt consistent with the ACC-AHA guideline_Paraskevas, jvs ++.pdf | 51.92Kb | February 10 2012 |
257.1202-CTA helps to differenciate acute from chronic carotid occlusion. The carotid ring sign_Michel, Neuroradiol.pdf | 379.85Kb | February 10 2012 |
259.1202-Current Dg and management of Sx IC AthS disease_Prabhakaran, Curr Opin Neurol.pdf | 210.41Kb | February 10 2012 |
274.1111ep-Synchronous CABG-CEA vs isolated CABG in patients with ASx cas. CABACS RCT-Knipp, Int J Stroke.pdf | 145.16Kb | February 10 2012 |
30.1202-US examinations by pocket-sized US devices improves inpatients Dgs in a medical department_Mjolstad, Eur J Intern Med.pdf | 388.85Kb | February 10 2012 |
31.1202-Mapping of the superficial veins. Normal diameters and trends in a vascular patient-population_Spivack, USMB.pdf | 290.56Kb | February 10 2012 |